Market News & Trends
Adaptimmune & Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products
Adaptimmune Therapeutics plc and Noile-Immune Biotech, Inc. recently announced they will co-develop next-generation SPEAR T-cell products, incorporating Noile-Immune’s PRIME (proliferation inducing and migration enhancing) technology,…
Hovione Signs Collaboration Agreement With Kiel University on High-Dose Dry Powder Inhalation Delivery
Hovione Technology recently announced it has entered into a collaboration agreement with Kiel University, Institute of Pharmacy in Germany, a reference research institution on inhaled drug delivery.
Gerresheimer Expands the Gx RTF ClearJect Product Line
Gerresheimer recently announced it is expanding its range of prefillable polymer syringes to include a new product: the Gx RTF ClearJect polymer needle syringe, 2.25 ml. Like the 1.0 ml syringe, this syringe will be……..
Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India
Ajinomoto Bio-Pharma Services recently announced its intention to purchase the remaining 50% ownership interest in its Visakhapatnam, India, joint venture, Granules OmniChem Private Limited (GOC) from its….
Ivy Brain Tumor Center & Salarius Pharmaceuticals Launch Collaborative Partnership
The Ivy Brain Tumor Center at the Barrow Neurological Institute and Salarius Pharmaceuticals, Inc. recently announced a collaborative partnership to test Salarius’ therapeutic candidate, Seclidemstat,…
Aptinyx Presents Data Demonstrating Positive Activity on Cognitive Performance & Biomarkers in a Preclinical Model
Aptinyx Inc. recently announced the presentation of preclinical data on its novel NMDA receptor modulator, NYX-458. The product candidate demonstrated positive recovery of performance on…
Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial
Landos Biopharma, Inc. recently announced dosing of the first patient in a Phase 2 study evaluating the safety and efficacy of BT-11 in patients with…
MyoKardia Begins Dosing in Phase 1 Clinical Study
MyoKardia, Inc. recently announced it has dosed the first subjects in a Phase 1 clinical study of MYK-224, a small molecule candidate being developed for…
Outlook Therapeutics Completes Patient Enrollment for Phase 3 Clinical Trial
Outlook Therapeutics, Inc. recently announced that it has completed patient enrollment in the NORSE 1 Phase 3 clinical trial, which is evaluating ONS-5010 against ranibizumab…
Altimmune Announces $3.7 Million in Additional BARDA Funding
Altimmune, Inc. recently announced the Biomedical Advanced Research and Development Authority (BARDA) is modifying its existing anthrax vaccine development contract with Altimmune by awarding an…
Cara Therapeutics Enters Commercial License Agreement With Enteris BioPharma
Cara Therapeutics, Inc. recently announced it has entered into a non-exclusive commercial license agreement with Enteris BioPharma, Inc. for oral formulation rights to…..
Viral Vectors Expected to Play Pivotal Role in Gene Therapy Pipeline for Neurology Indications
Viral vectors, such as adeno-associated virus (AAV), are expected to play a pivotal role in gene therapies for neurology indications, as this vector type has been found to be the most…..
Q BioMed & ChemVeda Announce Potential Chemotherapeutic Breakthrough
Q BioMed, Inc. and Chemveda Life Sciences recently announce the successful chemical synthesis of a unique natural compound that has shown remarkable efficacy as a potential………
Innovate Biopharmaceuticals Announces First Patient Dosed in the First Phase 3 Clinical Trial
Innovate Biopharmaceuticals, Inc. recently announced it has dosed the first patient in its Phase 3 clinical trial, CeD LA 3001. This marks the first time…
Oncologie Announces Clinical Trial Collaboration With Merck
Oncologie, Inc. recently announced it has entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to evaluate the…
Mustang Bio Announces $9.28-Million Grant to Fund Phase 1 Trial
Mustang Bio, Inc. recently announced that City of Hope has received a $9.28-million grant from the California Institute for Regenerative Medicine (CIRM) to fund an…
Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods
Bionano Genomics, Inc. recently announced a summary of results from two key studies presented this week at the 2019 Cancer Genomics Consortium Annual Meeting in…
Prostate Cancer Treatment Moving Toward Personalized Approach With 6 New Drugs in the Pipeline
Although options for prostate cancer have historically been limited, the late-stage prostate cancer pipeline holds promise for the future of this second most common cancer…
Cytovation & SMS-oncology Sign Agreement on Conduct of Phase 1/2 Trial
Cytovation AS and Specialized Medical Services-oncology BV recently announce that SMS-oncology has been selected as the CRO to conduct the Phase 1/2 clinical trial with…
AC Immune Announces Research Collaboration With University of Pennsylvania
AC Immune SA recently announced a research partnership with leading scientists in the Perelman School of Medicine at the University of Pennsylvania (Penn) focused on studying the pathological mechanisms of…..
